Zykadia

Drug - Zykadia™ (ceritinib) [Novartis Pharmaceutical Corporation]

November 2014

Therapeutic Area - Antineoplastic

Approval criteria

Patient must have a diagnosis of anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) AND
Patient has tried and failed Xalkori (crizotinib)

MHCP Provider Call Center 651-431-2700 or 800-366-5411